π MENU REFRESH π
This week's flower, every one with a COA. 21+ only.
ELITES
π Alien Vortex
π Blockberry
π Frozen Marker
π Italian Ice
π Lemon Berry
π Penzoil
π Platinum Life Hack
π Trichbeast
π White Boy Cookies
EXOTICS
β¨ Jake the Snake
β¨ Mendo Breath
β¨ Modified Grape
BUDGET
πΈ Astro
πΈ Candy Gas
πΈ Donny Burger
πΈ El Chivo
πΈ G41 x Donnie
πΈ G45 Punch
πΈ G45 x Trop
πΈ Keylime Jack
πΈ Lemonati
πΈ Mimosa
πΈ Mochie
πΈ OB x MF
πΈ Oreoz
πΈ Pink Runtz
πΏ DROP DAY πΏ
Blockberry Elite THCa Flower: 30% THCa
https://t.co/jhTYcmUlGL
+ Type: Hybrid
+ Aroma: Blueberry, citrus, gas
+ Effects: Uplifted, social, relaxed, body-eased
+ Lab tested, COA on site. 21+ only.
Smell-o-vision not included, unfortunately. You'll just have to try it...
Hemp policy update π
Federal changes to the legal definition of hemp are set to take effect Dec 11, 2026. We're following it closely and will keep you posted on what it means for our menu.
Want a plain-English breakdown? Reply 'yes' π
@usahaa_ Worth adding: full spectrum means the extract keeps its naturally occurring trace THC along with CBD, minor cannabinoids and terpenes. Under a 0.4 mg per container cap, many full spectrum products would need to become broad spectrum or isolate.
@echassisenjoyer@WuckMickett Gas-station carts definitely earned that rep. Good delta-8 still exists though.
Checklist for any vape: a third-party COA matched to the batch, a full panel for heavy metals and residual solvents, and a QR code that actually opens it. No COA, no purchase.
THCa 101 π§ͺ
THCa is a naturally occurring compound in raw hemp flower. Our COAs list THCa and delta-9 THC separately, so you know exactly what's in the jar.
Full guide: https://t.co/bX4AHbYK5e
π¨ This Week In Cannabis π¨
DEA issued its first federal registrations to 900+ medical dispensaries in seven states under the Schedule III medical pathway, with a November 29 supply-chain deadline for timely applicants.
Virginiaβs market is projected up to $1.27 billion, with recreational sales targeted for July 2027. Maryland legal sales topped $1 billion for 2026, the third straight year.
And a review of 13 randomized trials found inhaled cannabis made patients 60% more likely to achieve at least a 30% reduction in chronic non-cancer pain versus placebo.